Table 2.
Demographic Baseline Feature of Patients.
| Characteristics | Treatment group | Control group | P |
|---|---|---|---|
| Gender (male/female) | 7 (63.6%)/4 (36.4%) | 4 (36.4%)/7 (63.6%) | .2008 |
| Age (year) | 63.0 [53.0-71.0] | 63.0 [54.0-67.0] | .8965 |
| BMI | .9999 | ||
| Underweight | 1 (9.1%) | 0 (0.0%) | |
| Normal | 5 (45.5%) | 5 (45.5%) | |
| Overweight | 3 (27.3%) | 4 (36.4%) | |
| Obese | 2 (18.2%) | 2 (18.2%) | |
| Education level | .0460* | ||
| Middle school | 3 (27.3%) | 1 (9.1%) | |
| High school | 2 (18.2%) | 8 (72.7%) | |
| University | 6 (54.5%) | 2 (18.2%) | |
| Primary cancer type | .4481 | ||
| Lung | 3 (27.3%) | 1 (9.1%) | |
| Breast | 0 (0.0%) | 3 (27.3%) | |
| Liver | 1 (9.1%) | 1 (9.1%) | |
| Gastric | 1 (9.1%) | 2 (18.2%) | |
| Esophagus | 2 (18.2%) | 0 (0.0%) | |
| Prostate | 1 (9.1%) | 1 (9.1%) | |
| Others | 3 (27.3%) | 3 (27.3%) | |
| Working status (yes/no)† | 6 (54.5%)/5(45.5%) | 3 (27.3%)/8 (72.7%) | .3870 |
| Insomnia period | 14.0 [6.0-28.0] | 27.0 [4.0-36.0] | .5602 |
| ECOG-PS (0/1) | 7 (63.6%)/4 (36.4%) | 7 (63.6%)/4 (36.4%) | .9999 |
| TNM stage | .3579 | ||
| I | 5 (45.5%) | 1 (9.1%) | |
| II | 4 (36.4%) | 6 (54.5%) | |
| III | 1 (9.1%) | 1 (9.1%) | |
| IV | 1 (9.1%) | 2 (18.2%) | |
| NA | 0 (0.0%) | 1 (9.1%) | |
| Usage of hypnotics (yes/no) | 2 (18.2%)/9 (81.8%) | 3 (27.3%)/8 (72.7%) | .9999 |
| ISI score | 18.0 [15.0-22.0] | 18.0 [14.0-22.0] | .6034 |
Abbreviations: BMI, body mass index; ECOG-PS, Eastern Cooperative Oncology Group–Performance Status score; TNM, tumor nodes metastasis; ISI, Insomnia Severity Index.
*
P < .05.
†
Wilcoxon rank sum test to analyze with non-parametric statistics.